3. GOOD HEALTH AND WELL-BEING

Morgan Stanley rates HLS as Equal-weight – Marketscreener.com

Written by Amanda

While price earnings (PE) multiples have generally contracted for the Australian Healthcare sector, they remain above the
levels when the Australian 10 year bond yield was last around 4% in 2013, notes Morgan Stanley.

As a result, the broker favours those stocks where the growth outlook is now better than in 2013 or EPS certainty is high.

The Equal-weight rating and $3.75 target are retained for Healius. Industry view In-Line.

Sector: Health Care Equipment & Services.

Target price is $3.75.Current Price is $3.76. Difference: ($0.01) – (brackets indicate current price is over target). If HLS meets the Morgan Stanley target it will return approximately 0% (excluding dividends, fees and charges – negative figures indicate an expected loss).

© 2022 Acquisdata Pty Ltd., source FN Arena

Source: marketscreener.com

About the author

Amanda

Hi there, I am Amanda and I work as an editor at impactinvesting.ai;  if you are interested in my services, please reach me at amanda.impactinvesting.ai